School of Medicine


Showing 831-840 of 1,149 Results

  • Meghan Ramsey

    Meghan Ramsey

    Clinical Associate Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine

    BioDr. Meghan Ramsey is a Clinical Associate Professor in the Division of Pulmonary, Allergy, and Critical Care Medicine. She received her undergraduate degree from Lafayette College in Pennsylvania with a major in Neuroscience. She then attended Stanford University for medical school where she stayed to complete her internal medicine residency, and pulmonary/critical care fellowship. Her clinical time is split between the inpatient setting in the medical ICU and the ambulatory setting in Interventional Pulmonology with a focus on thoracic malignancies. Outside of her clinical time she has a dedicated commitment to teaching, serving as a mentor for residents and fellows, as well as leading as a co-director the pulmonary physiology course for medical students.

  • Julia D. Ransohoff

    Julia D. Ransohoff

    Instructor, Medicine - Oncology

    BioDr. Ransohoff received her B.A. from Harvard College in Human Developmental and Regenerative Biology and completed her medical training at Stanford University, where she received her M.D., completed residency in internal medicine, and fellowship training in hematology and oncology as part of the American Board of Internal Medicine Physician Scientist Training Program.

    Dr. Ransohoff is a physician-scientist dedicated to improving breast cancer treatments and outcomes through developing genomic methods to profile how tumors respond to treatment. Her research focuses on molecular approaches to understand the variable clinical responses of breast cancers to treatment at the genomic level by profiling molecular residual disease. Her current work involves exploring mechanisms of chemoresistance and immune evasion and identifying novel therapeutic targets. In related work, she also studies epidemiological risk factors for breast cancer mortality with a focus on the gut microbiome, oncofertility, and racial and ethnic differences in treatment response. Dr. Ransohoff's research has been supported by the ASCO Conquer Cancer Foundation, the Terri Brodeur Breast Cancer Foundation, the Stanford Cancer Institute, ECOG-ACRIN, and the Chan Zuckerberg Initiative.

    As an Instructor in the Division of Medical Oncology, Dr. Ransohoff is also a clinically active oncologist, treating patients with breast cancer.

  • Vishnu Ravi

    Vishnu Ravi

    Clinical Assistant Professor, Medicine - Primary Care and Population Health

    BioDr. Vishnu Ravi combines his expertise as a board-certified, practicing internal medicine physician, senior software engineer, and board-certified clinical informaticist to create transformative solutions for healthcare.

    As the Technology Architect for Stanford Medicine Catalyst, the Stanford School of Medicine's flagship innovation program, he designs, develops, and implements innovations including AI-driven platforms for Parkinson's care, chronic cardiovascular disease management, and precision pharmacogenomics that are helping patients receive more personalized and effective care.

    At the Stanford Mussallem Center for Biodesign, Vishnu helps lead the center's digital health initiatives spanning education, research, and translation. To support this work, he co-founded Stanford Spezi, an open-source framework and ecosystem for building modular, standards-based digital health solutions that is now used by leading healthcare institutions and companies worldwide.

    Vishnu also instructs Stanford's CS342/MED253 Building for Digital Health, an innovative course that brings together computer science, engineering, and medical students with clinical faculty to develop real-world healthcare applications. In 2025, he helped lead the international expansion of this program, with a successful launch at Chalmers University of Technology and University of Gothenburg in Sweden. He is also deeply involved in the effort to weave AI into the medical school curriculum at Stanford.

    Vishnu's entrepreneurial experience includes co-founding a TechStars-backed startup and developing COVID-19 solutions deployed internationally. He has pioneered clinical AI applications, creating conversational agents and advanced analytics for unstructured health data, while contributing to international mobile health data standards. He serves as a technical consultant to companies including Google and speaks regularly at industry conferences.

    Alongside his technology work, Vishnu maintains his connection to clinical practice as an Internal Medicine physician providing comprehensive primary care to a diverse patient population at Stanford Health Care.

  • Risheen Reejhsinghani

    Risheen Reejhsinghani

    Clinical Associate Professor, Medicine - Cardiovascular Medicine

    BioRisheen Reejhsinghani obtained her medical degree in Mumbai, India, followed by an internal medicine residency at St. Elizabeth's Medical Center in Boston, MA and cardiology fellowship at Baystate Medical Center/Tufts University School of Medicine, where she served as one of the chief fellows. She subsequently completed an advanced echocardiography fellowship at the University of California, San Francisco, and is board certified in echocardiography, general cardiology, and nuclear cardiology.

    Dr. Reejhsinghani practices as a general cardiologist in the Division of Cardiovascular Medicine at Stanford University School of Medicine, where she also serves as the associate director for the hospital-based consultative cardiology service. As a clinical cardiologist, she believes strongly in the tenets of evidence-based practice, diagnostic cognizance, and patient education. She also has a specific interest in the burgeoning field of Cardio-Rheumatology, focused on cardiac diseases among patients with rheumatologic conditions such as rheumatoid arthritis, systemic lupus erythematosus, scleroderma, and ankylosing spondylitis, among others. Her clinical research in this area has focused on the evaluation of structural cardiac disease and diastolic dysfunction in ankylosing spondylitis patients, primarily using echocardiography.

    Dr. Reejhsinghani has an academic focus in medical education, and believes that instilling a love for bedside medicine and the physical exam is the soundest way to empower future generations of learners. To this end, she received additional training in clinical teaching and simulation at the University of California, San Francisco, and has worked extensively on curriculum and course design. She currently serves as the associate program director of the cardiovascular medicine fellowship at Stanford, and is an associate course director for the Year 1 Practice of Medicine Course at the Stanford University medical school. Dr. Reejhsinghani also enjoys writing, particularly about medical education and has written articles for international newspapers, among other publications.

  • David Rehkopf

    David Rehkopf

    Professor of Epidemiology and Population Health, of Medicine (Primary Care and Population Health) and, by courtesy, of Pediatrics, of Health Policy and of Sociology

    BioI am a social epidemiologist and serve as a Professor in the Department of Epidemiology and Population Health and in the Department of Medicine in the Division of Primary Care and Population Health. I joined the faculty at Stanford School of Medicine in 2011.

    I am Director of the Stanford Center for Population Health Sciences. In this position, I am committed to making high-value data resources available to researchers across disciplines in order to better enable them to answer their most pressing clinical and population health questions.

    My own research is focused on understanding the health implications of the myriad decisions that are made by corporations and governments every day - decisions that profoundly shape the social and economic worlds in which we live and work. While these changes are often invisible to us on a daily basis, these seemingly minor actions and decisions form structural nudges that can create better or worse health at a population level. My work demonstrates the health implications of corporate and governmental decisions that can give the public and policy makers evidence to support new strategies for promoting health and well-being. In all of his work, I have a focus on the implications of these exposures for health inequalities.

    Since often policy and programmatic changes can take decades to influence health, my work also includes more basic research in understanding biological signals that may act as early warning signs of systemic disease, in particular accelerated aging. I examine how social and economic policy changes influence a range of early markers of disease and aging, with a particular recent focus on DNA methylation. I am supported by several grants from the National Institute on Aging and the National Institute on Minority Health and Health Disparities to develop new more sensitive ways to understand the health implications of social and economic policy changes.

  • David A. Relman

    David A. Relman

    Thomas C. and Joan M. Merigan Professor and Professor of Microbiology and Immunology

    Current Research and Scholarly InterestsMy investigative program focuses on human-microbe interactions and human microbial ecology, and primarily concerns the ecology of human indigenous microbial communities; a secondary interest concerns the classification of humans with systemic infectious diseases, based on features of genome-wide gene transcript abundance patterns and pther aspects of the host response.